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Introduction
Blau syndrome (BS) is a rare autosomal dominant,
autoinflammatory syndrome characterized by the clinical
triad of granulomatous, recurrent uveitis, dermatitis and
symmetric arthritis. Arthritis is usually a polyarticular
exuberant synovitis and tenosynovitis and represents the
characteristic phenotypic feature. Uveitis occurs in most
patients and commonly evolves to a panuveitis. In the
majority of patients, the disease is characterized by early
onset, usually before 3-4years of age. The gene responsi-
ble for BS has been identified in the caspase recruitment
domain gene NOD2/CARD15, and the most common
mutations were found in codon 334 (R334Q and
R334W). NOD2 is a member of a family of intracellular
proteins with N-terminal caspase recruitment domains
(CARDs). Since the first report of an association of the
NOD2 variants with Crohn disease by Hugot et al,
extensive studies have been focused on an association of
NOD2 with inflammatory bowel disease (IBD), pediatric
Blau syndrome, NOD2-associated autoinflammatory dis-
ease (NAID) and rheumatic disease.
Objectives
To identify the genotype-phenotype correlation of our
patient.
Methods
We describe a 4-year-old male, the first child of healthy
unrelated parents, who presented at 13 months of age,
with arthritis of the ankle and of the second proximal
inter-phalangeal of the right hand, without the typical
puffy appearance. Laboratory test revealed mild increase
in inflammatory parametrs (erythrocyte sedimentation
rate 35 mm/h, C-reactive protein 0.77 mg/dl) and the
presence of antinuclear antibody (titer 1:640, homoge-
neous pattern). A diagnosis of ANA positive oligoarticu-
lar juvenile idiopathic arthritis was made and an
infiltration of the ankle joint with TXA was performed,
with insufficient response. Persistence of the ankle
arthritis led to initiate treatment with methotrexate that
was not associated with clear benefit. Four months later
the patient developed recurrent episodes of fever and
skin rash on limbs and trunk, with spontaneous resolu-
tion, and subsequently recurrent episodes of bilateral
anterior uveitis.
Results
Based on the presence of persistent arthritis, recurrent
uveitis, fever and rash, Blau Syndrome was suspected
and molecular analysis of NOD2/CARD15 gene was
performed. Sequencing analysis demonstrated a hetero-
zygous c.802C>T mutation (P268S/SNP5) in exon 4.
Conclusion
Until now the c.802C>T mutation (P268S/SNP5) in
exon 4 of NOD2 had only been reported in association
with Crohn’s disease, rheumatoid arthritis, spondylar-
thropathy and ulcerative colitis. This is, to the best of
our knowledge, the first case of c.802C>T mutation
(P268S/SNP5) that appears to be associated with clinical
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